Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zt-12-037-01 is a ATP competitive STK19 inhibitor(IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N),respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 30.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 117.00 | |
25 mg | In stock | $ 236.00 | |
50 mg | In stock | $ 458.00 | |
100 mg | In stock | $ 673.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 75.00 |
Description | Zt-12-037-01 is a ATP competitive STK19 inhibitor(IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N),respectively). |
Targets&IC50 | STK19 (WT):23.96 nM , STK19 (D89N):27.94 nM |
In vitro | ZT-12-037-01 significantly inhibits mutant NRAS-STK19-driven melanocyte colony formation and proliferation. |
In vivo | ZT-12-037-01 as a specific STK19-targeted inhibitor and it effectively blocks oncogenic NRAS-driven melanocyte malignant transformation and melanoma growth in vivo. |
Animal Research | ZT-12-037-01 (injection subcutaneously; 25-50 mg/kg; once daily; 21 days) inhibits growth of SK-MEL-2 xenograft melanoma and the sections of tumors indicates induction of apoptosis by increasing cleaved caspase-3. |
Molecular Weight | 385.5 |
Formula | C21H31N5O2 |
CAS No. | 2328073-61-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 41 mg/mL (106.36 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ZT-12-037-01 2328073-61-4 GPCR/G Protein MAPK Proteases/Proteasome Serine Protease Ras inhibit ZT 12 037 01 ZT1203701 Inhibitor inhibitor